Dubourg, Julie et al
"Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial." Diabetes Care
(2021):
dc200763.
Web. 25 Feb. 2021.
